SLDB
Solid Biosciences Inc

6,132
Mkt Cap
$514.21M
Volume
832,422.00
52W High
$7.37
52W Low
$2.41
PE Ratio
-2.65
SLDB Fundamentals
Price
$6.46
Prev Close
$6.60
Open
$6.45
50D MA
$5.59
Beta
1.79
Avg. Volume
936,185.32
EPS (Annual)
-$3.06
P/B
2.36
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Solid Biosciences (NASDAQ:SLDB) Stock Price Up 11% - Should You Buy?
Solid Biosciences (NASDAQ:SLDB) Trading 11% Higher - Should You Buy...
MarketBeat·8d ago
News Placeholder
More News
News Placeholder
Will KROS Stock's Restructuring Efforts Reap Rewards for Investors?
Keros Therapeutics sharpens focus on KER-065 for DMD, cuts staff 45%, shelves cibotercept, and plans a phase II trial in Q1 2026 with cash runway into 2028.
Zacks·14d ago
News Placeholder
Needham & Company LLC Reiterates "Buy" Rating for Solid Biosciences (NASDAQ:SLDB)
Needham & Company LLC reaffirmed a "buy" rating and set a $16.00 target price on shares of Solid Biosciences in a report on Wednesday...
MarketBeat·16d ago
News Placeholder
Solid Biosciences Inc. (NASDAQ:SLDB) Given Average Recommendation of "Moderate Buy" by Analysts
Shares of Solid Biosciences Inc. (NASDAQ:SLDB - Get Free Report) have earned a consensus rating of "Moderate Buy" from the twelve research firms that are presently covering the company...
MarketBeat·24d ago
News Placeholder
Solid Biosciences (NASDAQ:SLDB) Shares Down 2.2% - Here's What Happened
Solid Biosciences (NASDAQ:SLDB) Trading Down 2.2% - Here's Why...
MarketBeat·25d ago
News Placeholder
Solid Biosciences Inc. (NASDAQ:SLDB) Given Average Recommendation of "Moderate Buy" by Brokerages
Shares of Solid Biosciences Inc. (NASDAQ:SLDB - Get Free Report) have earned an average recommendation of "Moderate Buy" from the twelve brokerages that are presently covering the firm...
MarketBeat·2mo ago
News Placeholder
Bollard Group LLC Acquires New Holdings in Solid Biosciences Inc. $SLDB
Bollard Group LLC bought a new position in shares of Solid Biosciences Inc. (NASDAQ:SLDB - Free Report) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm bought...
MarketBeat·2mo ago
News Placeholder
Geode Capital Management LLC Purchases 979,294 Shares of Solid Biosciences Inc. $SLDB
Geode Capital Management LLC raised its position in Solid Biosciences Inc. (NASDAQ:SLDB - Free Report) by 184.5% in the second quarter, according to its most recent disclosure with the SEC. The firm...
MarketBeat·2mo ago
News Placeholder
Jessie Hanrahan Sells 4,483 Shares of Solid Biosciences (NASDAQ:SLDB) Stock
Solid Biosciences Inc. (NASDAQ:SLDB - Get Free Report) insider Jessie Hanrahan sold 4,483 shares of the stock in a transaction that occurred on Wednesday, December 3rd. The shares were sold at an...
MarketBeat·2mo ago
News Placeholder
Solid Biosciences (NASDAQ:SLDB) CEO Sells 10,808 Shares
Solid Biosciences Inc. (NASDAQ:SLDB - Get Free Report) CEO Alexander Cumbo sold 10,808 shares of the firm's stock in a transaction that occurred on Wednesday, December 3rd. The shares were sold at an...
MarketBeat·2mo ago
<
1
2
...
>

Latest SLDB News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.